Clinical Trial Update: Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study. [Phase 1]

View source ↗

Summary

A randomized, open-label, three-crossover Phase 1 study assessing the pharmacokinetics of umeclidinium and vilanterol in healthy Chinese volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Umeclidinium (umeclidinium)
• Vilanterol (vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED